What’s Vulnerable › Vulnerabilities

CVE-2022-47376

• Severity: high (CVSS 7.3 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.2% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2023-06-13 · updated 2026-06-17
• Weakness: CWE-257

Description

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

Affected products

• Alaris Infusion Central: from 1.1 through 1.3.2

References

• https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerability
• https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerability

Get alerted when CVE-2022-47376 or the next vulnerability affects your stack